Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Liposarcoma × nilotinib × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 28 Leukemia 13 Gastrointestinal Stromal Tumors 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Leukemia, Myeloid, Chronic-Phase 6 Philadelphia Chromosome 3 Neoplasms 3 Leukemia, Myeloid 3 Hematologic Diseases 3 Bone Marrow Diseases 3 Myeloproliferative Disorders 2 Melanoma 2 Bronchiolitis Obliterans Syndrome 2 Blast Crisis 2 Synovitis, Pigmented Villonodular 1 Recurrence 1 Piebaldism 1 Neurofibromatoses 1 Neurofibroma, Plexiform 1 Neurofibroma 1 Neoplastic Processes 1 Neoplasms by Histologic Type 1 Neoplasm Metastasis 1 Mastocytosis, Systemic 1 Leukemia, Myeloid, Accelerated Phase 1 Hypereosinophilic Syndrome 1 Hematologic Neoplasms 1 Glioma 1 Giant Cell Tumor of Tendon Sheath 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Doxorubicin 6 pazopanib 4 Trabectedin 4 Radiotherapy 3 temsirolimus 2 eribulin 2 Sunitinib 2 Radiotherapy, Conformal 2 Ifosfamide 2 Dexamethasone 2 sitravatinib 1 selinexor 1 saracatinib 1 romidepsin 1 regorafenib 1 plitidepsin 1 pembrolizumab 1 palbociclib 1 olaratumab 1 milademetan 1 liposomal doxorubicin 1 lenvatinib 1 indolepropanol phosphate 1 efatutazone 1 cixutumumab 1 brigimadlin 1 avelumab 1 atezolizumab 1 Watchful Waiting 1 Topotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡